Medical couple and butcher's boy win big from Actelion sale | Reuters
Profile: Jean-Paul Clozel | Nature Biotechnology
Jean-Paul Clozel – Billionaire | Phnom Penh HR
Biotech visionary Jean-Paul Clozel: "Previous success can be a big handicap," - YouTube
Idorsia : Transforming the Horizons of Therapeutic Options | Insights Care
Big Boss - Jean-Paul Clozel, CEO Idorsia - Play RTS
Our CEO, Jean-Paul Clozel... - Idorsia Pharmaceuticals Ltd | Facebook
Actelion wins FDA approval for hypertension drug - San Francisco Business Times
Der Manager des Jahres heisst Jean-Paul Clozel | Finanz und Wirtschaft
Actelion's Jean-Paul Clozel aims to keep group's independence | Financial Times
Idorsia, a small company with a big portfolio says Martine Clozel
Biotech: Jean-Paul Clozel kämpft bei Idorsia mit Gegenwind
Jean-Paul Clozel | Financial Times
Actelion CEO Becomes a Billionaire With J&J's Bid for Drugmaker - Bloomberg
Jean-Paul Clozel - CEO @ Idorsia - Crunchbase Person Profile
Was plant das Ehepaar Clozel? | NZZ
Idorsia insomnia drug starts FDA review as founder Clozel's second act proceeds | Reuters
Johnson & Johnson Chief Scientific Officer Pharmaceuticals Paul Stoffels (C) and Actelion CEO and founder Jean-Paul Clozel (R) attend a news conference at Actelion headquarters in Allschwil, Switzerland January 26, 2017. REUTERS/Arnd
Jean-Paul Clozel | EY - Global
Jean-Paul Clozel
PharmaBoardroom - Jean-Paul Clozel - CEO, Idorsia
Jean-Paul Clozel
Actelion-Gründer erhalten Preis der Vereinigung Starkes Basel
Jean-Paul Clozel
